Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2013 04:31 ET | Source: Evotec AG

Evotec AG: Results of Pre-Clinical Studies Lead to Reduction in Revenues, Nevertheless Profitable and More Than EURO 90 M Cash for 2013 Confirmed

HAMBURG, Germany, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that it is adjusting its guidance regarding...
December 10, 2013 01:46 ET | Source: Evotec AG

Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...
November 12, 2013 01:56 ET | Source: Evotec AG

Evotec AG Reports First Nine Months 2013 Results

DRIVING INNOVATION AND CAPITAL EFFICIENCY WITH STRONG LIQUIDITY POSITION POSITIVE NEWS FLOW CHARACTERISES THIRD QUARTER 2013 HAMBURG, Germany, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Evotec AG...
November 08, 2013 01:28 ET | Source: Evotec AG

Evotec Announces TargetAD Collaboration With Johnson & Johnson Innovation to Identify and Develop Novel Alzheimer's Disease Therapies

Collaborative effort will explore genes dysregulated in Alzheimer's disease patients to identify new targets for drug discovery and development HAMBURG, Germany, Nov. 8, 2013 (GLOBE NEWSWIRE)...
November 06, 2013 04:00 ET | Source: Evotec AG

Evotec to Report Results for the First Nine Months of 2013 on 12 November 2013

HAMBURG, Germany, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first nine months of 2013 on Tuesday, 12 November...
November 05, 2013 01:37 ET | Source: Evotec AG

Evotec and The Leukemia & Lymphoma Society Enter Into a Strategic Research Collaboration

HAMBURG, Germany, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that it has entered into an integrated research collaboration with The...
October 28, 2013 02:44 ET | Source: Evotec AG

Evotec Achieves First Milestones in Multi-Target Deal With UCB

HAMBURG, Germany, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has achieved first milestones in its multi-year, multi-target...
October 21, 2013 01:47 ET | Source: Evotec AG

Evotec Enters Integrated Alliance With AstraZeneca in Kidney Disease

HAMBURG, Germany, Oct. 21, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) today announced that it has signed an agreement with AstraZeneca in the field of kidney...
October 16, 2013 08:09 ET | Source: Evotec AG

Evotec to Hold R&D Day 2013

HAMBURG, Germany, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN: DE0005664809) announced today that its R&D Day 2013 will take place on 22 October 2013 in New York...
October 15, 2013 01:36 ET | Source: Evotec AG

Evotec Receives Pre-Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...